IV immunoglobulin might be considered as a first-line treatment of severe interstitial lung disease associated with polymyositis

Chest

Volumn 140, Issue 2, 2011, Pages 562-563

  Diot, Elisabeth ^a,b   Carmier, Delphine ^a   Marquette, David ^a   Marchand Adam, Sylvain ^a,b   Diot, Patrice ^a,b   Lesire, Vincent ^c  

^a CHU BRETONNEAU   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c GTR IUT de Blois   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARBON MONOXIDE; CREATINE KINASE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; JO 1 ANTIBODY; PREDNISONE;

ADULT; BRONCHOGRAPHY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; DISEASE ASSOCIATION; DRUG WITHDRAWAL; DYSPNEA; ELECTROMYOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LETTER; LUNG DIFFUSION CAPACITY; MALE; MUSCLE BIOPSY; POLYMYOSITIS; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY; TREATMENT OUTCOME; VITAL CAPACITY; WEAKNESS;

EID: 80051514052     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-0492     Document Type: Letter

References (4)

1. Bakewell CJ, Raghu G. Polymyositis associated with severe interstitial lung disease: remission after three doses of IV immunoglobulin. Chest. 2011;139(2):441-443.
2. Yamasaki Y, Yamada H, Yamasaki M, et al. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis. Rheumatology (Oxford). 2007;46(1):124-130. (Pubitemid 44932799)
3. Conners GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest. 2010;138(6):1464-1474.
4. Suzuki Y, Hayakawa H, Miwa S, et al. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/ dermatomyositis. Lung. 2009;187(3):201-206.